- 米国企業
- DR REDDYS LABORATORIES LTD
DR REDDYS LABORATORIES LTDRDY
| 2019年 3月31日 | 2020年 3月31日 | 2021年 3月31日 | 2022年 3月31日 | 2023年 3月31日 |
---|
Cash and cash equivalents | 32 | 27 | 203 | 196 | 70 |
---|
Other investments | 326 | 314 | 270 | 389 | 682 |
---|
Trade and other receivables | 576 | 667 | 679 | 880 | 882 |
---|
Inventories | 486 | 465 | 621 | 671 | 592 |
---|
Derivative financial instruments | 5 | 15 | 17 | 25 | 15 |
---|
Tax assets | 49 | 58 | 38 | 53 | 33 |
---|
Other current assets | 181 | 183 | 198 | 183 | 244 |
---|
Total current assets | 1,656 | 1,729 | 2,027 | 2,397 | 2,518 |
---|
Property, plant and equipment | 782 | 694 | 781 | 819 | 809 |
---|
Goodwill | 56 | 53 | 62 | 58 | 52 |
---|
Other intangible assets | 642 | 367 | 487 | 359 | 375 |
---|
Trade and other receivables | 2 | 23 | 2 | 1 | - |
---|
Investment in equity accounted investees | 37 | 37 | 46 | 57 | 57 |
---|
Other investments | 12 | 4 | 68 | 48 | 8 |
---|
Deferred tax assets | 60 | 162 | 145 | 108 | 88 |
---|
Other non-current assets | 14 | 11 | 11 | 12 | 10 |
---|
Total non-current assets | 1,604 | 1,351 | 1,603 | 1,463 | 1,398 |
---|
Total assets | 3,259 | 3,081 | 3,630 | 3,860 | 3,916 |
---|
Trade and other payables | 210 | 221 | 325 | 337 | 322 |
---|
Short-term Debt | 175 | 218 | 316 | 357 | 90 |
---|
Long-term borrowings, current portion | 62 | 57 | 12 | 13 | 58 |
---|
Provisions | - | 50 | 47 | 56 | 66 |
---|
Tax liabilities | 3 | 8 | 19 | 21 | 26 |
---|
Derivative financial instruments | 1 | 21 | 4 | 6 | 2 |
---|
Other current liabilities | 352 | 390 | 417 | 448 | 480 |
---|
Total current liabilities | 863 | 966 | 1,140 | 1,239 | 1,044 |
---|
Long-term borrowings | 318 | 17 | 86 | 76 | 16 |
---|
Deferred tax liabilities | 9 | 4 | 5 | 1 | 10 |
---|
Provisions | - | 1 | 1 | 1 | 1 |
---|
Other non-current liabilities | 41 | 37 | 32 | 32 | 35 |
---|
Total non-current liabilities | 369 | 59 | 124 | 109 | 61 |
---|
Total liabilities | 1,232 | 1,025 | 1,264 | 1,348 | 1,106 |
---|
Share capital | 12 | 11 | 11 | 11 | 10 |
---|
Treasury shares | 8 | 13 | 27 | 21 | 15 |
---|
Share premium | 119 | 113 | 122 | 122 | 118 |
---|
Share-based payment reserve | 14 | 16 | 20 | 21 | 20 |
---|
Capital redemption reserve | 2 | 2 | 2 | 2 | 2 |
---|
Debenture redemption reserve | - | - | - | 4 | 5 |
---|
Special Economic Zone Reinvestment Reserve | - | - | 18 | 10 | 11 |
---|
Retained earnings | 1,860 | 1,913 | 2,133 | 2,316 | 2,623 |
---|
Other reserves | - | 13 | 87 | 45 | 37 |
---|
Total equity | 2,027 | 2,056 | 2,366 | 2,511 | 2,810 |
---|
Total liabilities and equity | 3,259 | 3,081 | 3,630 | 3,860 | 3,916 |
---|